The press release of Dr. Wiestner of the NIH on the one year data on single agent ibrutinib with no other drugs to help in 17p del and > 65 patients, with my commentary: bkoffman.blogspot.com/2013/...
Bottom line: 94% event free survival at one year. WOW!